Can sapropterin alone completely cure pku?

Can sapropterin alone cure PKU?

Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), the natural cofactor for phenylalanine hydroxylase (PAH). It helps patients with certain mutations in the PAH gene stabilize the enzyme and improve its activity. Only patients who respond to the sapropterin challenge test can benefit from it. Sapropterin reduces blood phenylalanine levels in responders, but it does not repair the defective gene itself. Therefore, sapropterin alone cannot cure PKU.

How does sapropterin work in PKU responders?

It lowers blood phenylalanine by increasing the activity of whatever restorable enzyme function remains. In responders, blood phenylalanine can often be kept below treatment targets with sapropterin plus a milder phenylalanine intake. This allows some responders to relax strict dietary controls. It does not work in classical PKU patients with two severe mutations.

What happens if a patient stops taking sapropterin?

Stopping sapropterin restores the ursprüngliche hohe phenylalanine levels in responders. High phenylalanine comes back within days of discontinuation. High phenylalanine risks neurocognitive damage, especially in developing brains. Patients must continue lifelong management whether they are responders or non-responders.

What alternatives exist if sapropterin does not work?

Dietary phenylalanine restriction remains the established treatment for all PKU patients. Dietary management is combined with medical foods and protein substitutes. Newer alternatives include pegvaliase, an enzyme substitution therapy that fully breaks down phenylalanine. Pegvaliase can achieve normal phenylalanine levels in many patients, but it requires risk management for anakinra-like anaphylaxis risk.

When does the sapropterin patent expire?

The compound itself is off-patent. Generic sapropterin dihydrochloride is already available from multiple manufacturers.